Impact of a Health Intervention on Some Indicators in the Care of Chronic Complex Patient (CCP).

NCT03091036 | Completed

• 1 other identifier: InveCuidPCC16
• Study Type: interventional
• Target: 28
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to assess the effectiveness of proactive and integrated healthcare program for chronic complex patients (CCP). This program are based in coordination the primary level of attention with and speciality level. The objective is reducing hospital readmissions and know the benefit in total cost of care in 4 month before and 4 after intervention.

Conditions

Preventive Care

Keywords

Chronic; Complex

Outcome Measures

Primary Outcomes (1)

• Pre-post change in days of Hospital stay from baseline to 16 weeks.

  The same group of patients are analyzed the days of hospital stay at the end of 16 weeks of follow-up pre intervention (baseline) and 16 week after the intervention.

  Baseline and 16 weeks.

Secondary Outcomes (3)

• Number of hospital readmissions visits for CCP change from baseline to 16 weeks.

  Baseline and 16 weeks.

• Number of urgency visits for CCP change from baseline to 16 weeks.

  Baseline and 16 weeks.

• Number of primary care visits for CCP change from baseline to 16 weeks.

  Baseline and 16 weeks.

Study Arms (1)

Proactive healthcare intervention

OTHER

Participants who were included before (single-arm pre-post study), now a proactive and integrated intervention program for the health is performed of the complex chronic patient, based in an improvement of the care process.

Other: Proactive healthcare intervention

Interventions

Proactive healthcare intervention OTHER

There is an intervention in the coordination of health resources, and monitoring readmissions and know the benefit in total cost of care in 4 month.

Proactive healthcare intervention

Eligibility Criteria

• Age: 75 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Patient ≥ 75 years.
• Having attended 5 or more emergency visits or having had more than 3 hospital admissions in the last 12 months.
• Identified with social risk alert.

You may not qualify if:

• Participate in other health programs (AHT, diabetes mellitus,...).
• Terminal patient.

Sponsors & Collaborators

• María José del Olmo Rubio: lead
• Hospital Universitario 12 de Octubre: collaborator

Study Sites (1)

Hospital Universitario 12 de Octubre de Madrid

Madrid, Madrid, 28041, Spain

Location

MeSH Terms

Conditions

Bronchiolitis Obliterans Syndrome

Condition Hierarchy (Ancestors)

Organizing Pneumonia; Bronchiolitis Obliterans; Bronchiolitis; Bronchitis; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Graft vs Host Disease; Immune System Diseases

Study Officials

• María José del Olmo Rubio

  Hospital 12 de Octubre de Madrid

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: March 16, 2017
• First Posted: March 27, 2017
• Study Start: July 1, 2015
• Primary Completion: July 1, 2016
• Study Completion: January 1, 2017
• Last Updated: April 10, 2017

Record last verified: 2017-04

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)